Merck KGaA: Bio-Techne Acquisition Improves Quality, But The Stock Seems Fully Valued (Downgrade)
We bridge the gap between financial information and actionable insight by providing unrivaled coverage on all asset classes and access to best-in-class tools. Invest.","telephone":"+1-347-509-6837","url":"https://seekingalpha.com"},"datePublished":"2026-06-26T02:45:53.000Z","dateModified":"2026-06-26T02:48:16.000Z","description":"Merck KGaA (MKGAF) Q1 beat and Bio-Techne deal drive upside, but valuation looks full. I wrote this article myself, and it expresses my own opinions.
- ▪We bridge the gap between financial information and actionable insight by providing unrivaled coverage on all asset classes and access to best-in-class tools.
- ▪Invest.","telephone":"+1-347-509-6837","url":"https://seekingalpha.com"},"datePublished":"2026-06-26T02:45:53.000Z","dateModified":"2026-06-26T02:48:16.000Z","description":"Merck KGaA (MKGAF) Q1 beat and Bio-Techne deal drive upside, but va
- ▪I wrote this article myself, and it expresses my own opinions.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://seekingalpha.com/"},{"@type":"ListItem","position":2,"name":"Healthcare ","item":"https://seekingalpha.com/stock-ideas/healthcare"}]}{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4917901-merck-kgaa-bio-techne-acquisition-improves-quality-but-stock-seems-fully-valued-downgrade"},"author":{"@type":"Person","name":"Wolf Report","url":"https://seekingalpha.com/author/wolf-report"},"publisher":{"@context":"https://schema.org","@type":"Organization","address":{"@type":"PostalAddress","streetAddress":"244 5th Ave","addressLocality":"New…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Seeking Alpha.
Discussion
0 commentsMore from Seeking Alpha
